Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Diana Balenovic

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Acta Medica Croatica : Casopis Hravatske Akademije Medicinskih Znanosti|May 28, 2015
[Importance of standardized stepwise screening in patients with resistant hypertension]Ingrid Prkačin, Diana Balenovic, Gordana Cavrić, et al.
Materia Socio-Medica|May 26, 2015
Resistant hypertension and chronotherapyIngrid Prkacin, Diana Balenovic, Vesna Djermanovic-Dobrota, et al.
European Journal of Pharmacology|November 6, 2016
Stable gastric pentadecapeptide BPC 157 and bupivacaineGordana Zivanovic-Posilovic, Diana Balenovic, Ivan Barisic, et al.
Regulatory Peptides|January 19, 2013
Mortal hyperkalemia disturbances in rats are NO-system related. The life saving effect of pentadecapeptide BPC 157Ivan Barisic, Diana Balenovic, Robert Klicek, et al.
Biomedicines|August 6, 2021
Stable Gastric Pentadecapeptide BPC 157 Therapy for Monocrotaline-Induced Pulmonary Hypertension in Rats Leads to Prevention and ReversalMario Udovicic, Marko Sever, Lovro Kavur, et al.
Pharmaceuticals (Basel, Switzerland)|March 28, 2026
Cytoprotection as a Unifying Strategy for Hemorrhage and Thrombosis: The Role of BPC 157 and Related TherapeuticsPredrag Sikiric, Ivan Barisic, Mario Udovicic, et al.
Biomedicines|February 25, 2022
Stable Gastric Pentadecapeptide BPC 157 May Counteract Myocardial Infarction Induced by Isoprenaline in RatsIvan Barisic, Diana Balenovic, Mario Udovicic, et al.
Pharmaceuticals (Basel, Switzerland)|February 27, 2026
Conventional Antiarrhythmics Class I-IV, Late INa Inhibitors, IKs Enhancers, RyR2 Stabilizers, Gap Junction Modulators, Atrial-Selective Antiarrhythmics, and Stable Gastric Pentadecapeptide BPC 157 as Useful Cytoprotective Therapy in ArrhythmiasPredrag Sikiric, Ivan Barisic, Mario Udovicic, et al.
Biomedicines|November 11, 2022
Stable Gastric Pentadecapeptide BPC 157 as Useful Cytoprotective Peptide Therapy in the Heart Disturbances, Myocardial Infarction, Heart Failure, Pulmonary Hypertension, Arrhythmias, and Thrombosis PresentationPredrag Sikiric, Mario Udovicic, Ivan Barisic, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Acta Medica Croatica : Casopis Hravatske Akademije Medicinskih Znanosti|May 28, 2015
[Importance of standardized stepwise screening in patients with resistant hypertension]Ingrid Prkačin, Diana Balenovic, Gordana Cavrić, et al.
Materia Socio-Medica|May 26, 2015
Resistant hypertension and chronotherapyIngrid Prkacin, Diana Balenovic, Vesna Djermanovic-Dobrota, et al.
European Journal of Pharmacology|November 6, 2016
Stable gastric pentadecapeptide BPC 157 and bupivacaineGordana Zivanovic-Posilovic, Diana Balenovic, Ivan Barisic, et al.
Regulatory Peptides|January 19, 2013
Mortal hyperkalemia disturbances in rats are NO-system related. The life saving effect of pentadecapeptide BPC 157Ivan Barisic, Diana Balenovic, Robert Klicek, et al.
Biomedicines|August 6, 2021
Stable Gastric Pentadecapeptide BPC 157 Therapy for Monocrotaline-Induced Pulmonary Hypertension in Rats Leads to Prevention and ReversalMario Udovicic, Marko Sever, Lovro Kavur, et al.
Pharmaceuticals (Basel, Switzerland)|March 28, 2026
Cytoprotection as a Unifying Strategy for Hemorrhage and Thrombosis: The Role of BPC 157 and Related TherapeuticsPredrag Sikiric, Ivan Barisic, Mario Udovicic, et al.
Biomedicines|February 25, 2022
Stable Gastric Pentadecapeptide BPC 157 May Counteract Myocardial Infarction Induced by Isoprenaline in RatsIvan Barisic, Diana Balenovic, Mario Udovicic, et al.
Pharmaceuticals (Basel, Switzerland)|February 27, 2026
Conventional Antiarrhythmics Class I-IV, Late INa Inhibitors, IKs Enhancers, RyR2 Stabilizers, Gap Junction Modulators, Atrial-Selective Antiarrhythmics, and Stable Gastric Pentadecapeptide BPC 157 as Useful Cytoprotective Therapy in ArrhythmiasPredrag Sikiric, Ivan Barisic, Mario Udovicic, et al.
Biomedicines|November 11, 2022
Stable Gastric Pentadecapeptide BPC 157 as Useful Cytoprotective Peptide Therapy in the Heart Disturbances, Myocardial Infarction, Heart Failure, Pulmonary Hypertension, Arrhythmias, and Thrombosis PresentationPredrag Sikiric, Mario Udovicic, Ivan Barisic, et al.
Pageof 1